NKTR | | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | Feb 20, 2024 | Sale | $0.68 | 9,014 | 6,130 | 265,025 | Feb 22, 2024, 08:19 PM |
NKTR | | NEKTAR THERAPEUTICS | Wilson Mark Andrew | Chief Legal Officer | Feb 20, 2024 | Sale | $0.68 | 7,606 | 5,172 | 236,674 | Feb 22, 2024, 08:17 PM |
NKTR | | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | Feb 20, 2024 | Sale | $0.68 | 20,033 | 13,622 | 879,889 | Feb 22, 2024, 08:16 PM |
NKTR | | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | Nov 17, 2023 | Sale | $0.49 | 9,646 | 4,727 | 274,039 | Nov 20, 2023, 09:02 PM |
NKTR | | NEKTAR THERAPEUTICS | Wilson Mark Andrew | Chief Legal Officer | Nov 17, 2023 | Sale | $0.49 | 7,179 | 3,518 | 243,780 | Nov 20, 2023, 09:00 PM |
NKTR | | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | Nov 17, 2023 | Sale | $0.49 | 19,877 | 9,740 | 899,922 | Nov 20, 2023, 08:58 PM |
NKTR | | NEKTAR THERAPEUTICS | Curet Myriam | Director | Sep 18, 2023 | Sale | $0.69 | 4,359 | 3,008 | 27,418 | Sep 20, 2023, 08:09 PM |
NKTR | | NEKTAR THERAPEUTICS | CHESS ROBERT | Director | Sep 22, 2022 | Sale | $0.67 | 10,200 | 6,834 | 274,773 | Sep 20, 2023, 08:08 PM |
NKTR | | NEKTAR THERAPEUTICS | Ajer Jeffrey Robert | Director | Sep 18, 2023 | Sale | $0.69 | 4,359 | 3,008 | 34,153 | Sep 20, 2023, 08:06 PM |
NKTR | | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | Aug 16, 2023 | Sale | $0.78 | 9,703 | 7,568 | 283,685 | Aug 17, 2023, 08:08 PM |
NKTR | | NEKTAR THERAPEUTICS | Wilson Mark Andrew | Chief Legal Officer | Aug 16, 2023 | Sale | $0.78 | 7,221 | 5,632 | 250,959 | Aug 17, 2023, 08:07 PM |
NKTR | | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | Aug 16, 2023 | Sale | $0.78 | 19,998 | 15,598 | 919,799 | Aug 17, 2023, 08:06 PM |
NKTR | | NEKTAR THERAPEUTICS | WHITFIELD ROY A | Director | Jun 14, 2023 | Sale | $0.57 | 30,000 | 17,100 | 216,250 | Jun 15, 2023, 06:26 PM |
NKTR | | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | May 16, 2023 | Sale | $0.72 | 9,791 | 7,050 | 293,388 | May 17, 2023, 08:29 PM |
NKTR | | NEKTAR THERAPEUTICS | Wilson Mark Andrew | Chief Legal Officer | May 16, 2023 | Sale | $0.72 | 7,543 | 5,431 | 257,680 | May 17, 2023, 08:28 PM |
NKTR | | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | May 16, 2023 | Sale | $0.72 | 20,361 | 14,660 | 939,797 | May 17, 2023, 08:27 PM |
NKTR | | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | Feb 16, 2023 | Sale | $3.00 | 10,484 | 31,452 | 303,179 | Feb 17, 2023, 09:00 PM |
NKTR | | NEKTAR THERAPEUTICS | Wilson Mark Andrew | Chief Legal Officer | Feb 16, 2023 | Sale | $3.00 | 8,275 | 24,825 | 265,223 | Feb 17, 2023, 08:59 PM |
NKTR | | NEKTAR THERAPEUTICS | Thomsen Jillian B. | Chief Financial Officer | Feb 16, 2023 | Sale | $3.00 | 10,267 | 30,801 | 313,497 | Feb 17, 2023, 08:58 PM |
NKTR | | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | Feb 16, 2023 | Sale | $3.00 | 19,635 | 58,905 | 960,158 | Feb 17, 2023, 08:57 PM |
NKTR | | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | Nov 16, 2022 | Sale | $3.57 | 13,460 | 48,052 | 313,663 | Nov 18, 2022, 06:05 PM |
NKTR | | NEKTAR THERAPEUTICS | Wilson Mark Andrew | Chief Legal Officer | Nov 16, 2022 | Sale | $3.57 | 8,690 | 31,023 | 272,498 | Nov 18, 2022, 06:04 PM |
NKTR | | NEKTAR THERAPEUTICS | Thomsen Jillian B. | Chief Financial Officer | Nov 16, 2022 | Sale | $3.57 | 11,095 | 39,609 | 323,764 | Nov 18, 2022, 06:03 PM |
NKTR | | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | Nov 16, 2022 | Sale | $3.57 | 38,014 | 135,710 | 979,793 | Nov 18, 2022, 06:02 PM |
NKTR | | NEKTAR THERAPEUTICS | Curet Myriam | Director | Sep 23, 2022 | Sale | $3.16 | 4,198 | 13,266 | 31,777 | Sep 26, 2022, 07:32 PM |
NKTR | | NEKTAR THERAPEUTICS | Ajer Jeffrey Robert | Director | Sep 23, 2022 | Sale | $3.16 | 4,198 | 13,266 | 38,512 | Sep 26, 2022, 07:25 PM |
NKTR | | NEKTAR THERAPEUTICS | CHESS ROBERT | Director | Sep 22, 2022 | Sale | $3.19 | 5,100 | 16,269 | 228,179 | Sep 26, 2022, 07:23 PM |
NKTR | | NEKTAR THERAPEUTICS | EASTHAM KARIN | Director | Sep 13, 2022 | Sale | $3.61 | 21,267 | 76,774 | 13,033 | Sep 14, 2022, 06:01 PM |
NKTR | | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | Aug 18, 2022 | Sale | $4.65 | 73,716 | 342,779 | 327,123 | Aug 19, 2022, 06:27 PM |
NKTR | | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | Aug 16, 2022 | Sale | $4.76 | 10,560 | 50,266 | 400,839 | Aug 17, 2022, 07:41 PM |
NKTR | | NEKTAR THERAPEUTICS | Wilson Mark Andrew | SVP & General Counsel | Aug 16, 2022 | Sale | $4.76 | 3,189 | 15,180 | 281,188 | Aug 17, 2022, 07:40 PM |
NKTR | | NEKTAR THERAPEUTICS | Thomsen Jillian B. | SVP & Chief Accounting Officer | Aug 16, 2022 | Sale | $4.76 | 2,006 | 9,549 | 334,859 | Aug 17, 2022, 07:40 PM |
NKTR | | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | Aug 16, 2022 | Sale | $4.76 | 13,759 | 65,493 | 1,017,807 | Aug 17, 2022, 07:39 PM |
NKTR | | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | May 16, 2022 | Sale | $3.95 | 21,673 | 85,608 | 276,399 | May 17, 2022, 09:40 PM |
NKTR | | NEKTAR THERAPEUTICS | Wilson Mark Andrew | SVP & General Counsel | May 16, 2022 | Sale | $3.95 | 3,136 | 12,387 | 117,939 | May 17, 2022, 09:38 PM |
NKTR | | NEKTAR THERAPEUTICS | Thomsen Jillian B. | SVP & Chief Accounting Officer | May 16, 2022 | Sale | $3.95 | 5,841 | 23,072 | 170,427 | May 17, 2022, 09:36 PM |
NKTR | | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | May 16, 2022 | Sale | $3.95 | 36,529 | 144,290 | 620,941 | May 17, 2022, 09:35 PM |
NKTR | | NEKTAR THERAPEUTICS | NORTHCOTT JOHN | SVP & Chief Commercial Officer | May 16, 2022 | Sale | $3.95 | 4,592 | 18,138 | 223,210 | May 17, 2022, 09:33 PM |
NKTR | | NEKTAR THERAPEUTICS | Labrucherie Gil M | SVP, COO & CFO | May 16, 2022 | Sale | $3.95 | 17,448 | 68,920 | 312,905 | May 17, 2022, 09:32 PM |
NKTR | | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | Feb 16, 2022 | Sale | $10.95 | 10,912 | 119,486 | 274,122 | Feb 18, 2022, 06:20 PM |
NKTR | | NEKTAR THERAPEUTICS | Wilson Mark Andrew | SVP & General Counsel | Feb 16, 2022 | Sale | $10.95 | 3,661 | 40,088 | 121,075 | Feb 18, 2022, 06:18 PM |
NKTR | | NEKTAR THERAPEUTICS | Thomsen Jillian B. | SVP & Chief Accounting Officer | Feb 16, 2022 | Sale | $10.95 | 2,363 | 25,875 | 165,318 | Feb 18, 2022, 06:18 PM |
NKTR | | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | Feb 16, 2022 | Sale | $10.95 | 12,480 | 136,656 | 589,020 | Feb 18, 2022, 06:16 PM |
NKTR | | NEKTAR THERAPEUTICS | NORTHCOTT JOHN | SVP & Chief Commercial Officer | Feb 16, 2022 | Sale | $10.95 | 4,852 | 53,129 | 227,802 | Feb 18, 2022, 06:15 PM |
NKTR | | NEKTAR THERAPEUTICS | Labrucherie Gil M | SVP, COO & CFO | Feb 16, 2022 | Sale | $10.95 | 7,579 | 82,990 | 301,603 | Feb 18, 2022, 06:14 PM |
NKTR | | NEKTAR THERAPEUTICS | Labrucherie Gil M | SVP, COO & CFO | Nov 18, 2021 | Sale | $12.69 | 3,000 | 38,070 | 256,682 | Nov 18, 2021, 06:06 PM |
NKTR | | NEKTAR THERAPEUTICS | Labrucherie Gil M | SVP, COO & CFO | Nov 16, 2021 | Sale | $13.16 | 21,149 | 278,321 | 259,682 | Nov 18, 2021, 06:06 PM |
NKTR | | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | Nov 16, 2021 | Sale | $13.16 | 20,869 | 274,636 | 232,084 | Nov 17, 2021, 06:11 PM |
NKTR | | NEKTAR THERAPEUTICS | Wilson Mark Andrew | SVP & General Counsel | Nov 16, 2021 | Sale | $13.16 | 6,564 | 86,382 | 86,436 | Nov 17, 2021, 06:09 PM |
NKTR | | NEKTAR THERAPEUTICS | Thomsen Jillian B. | SVP & Chief Accounting Officer | Nov 16, 2021 | Sale | $13.16 | 6,741 | 88,712 | 145,981 | Nov 17, 2021, 06:08 PM |
NKTR | | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | Nov 16, 2021 | Sale | $13.16 | 42,773 | 562,893 | 475,450 | Nov 17, 2021, 06:07 PM |
NKTR | | NEKTAR THERAPEUTICS | NORTHCOTT JOHN | SVP & Chief Commercial Officer | Nov 16, 2021 | Sale | $13.16 | 6,061 | 79,763 | 194,854 | Nov 17, 2021, 06:06 PM |
NKTR | | NEKTAR THERAPEUTICS | GREER R SCOTT | Director | Nov 09, 2021 | Option Exercise | $12.80 | 12,500 | 160,000 | 293,374 | Nov 09, 2021, 05:05 PM |
NKTR | | NEKTAR THERAPEUTICS | Curet Myriam | Director | Sep 22, 2021 | Sale | $17.78 | 3,665 | 65,164 | 25,775 | Sep 24, 2021, 06:14 PM |
NKTR | | NEKTAR THERAPEUTICS | CHESS ROBERT | Director | Sep 22, 2021 | Sale | $17.94 | 4,600 | 82,524 | 279,873 | Sep 24, 2021, 06:13 PM |
NKTR | | NEKTAR THERAPEUTICS | Ajer Jeffrey Robert | Director | Sep 22, 2021 | Sale | $17.78 | 3,665 | 65,164 | 32,510 | Sep 24, 2021, 06:12 PM |
NKTR | | NEKTAR THERAPEUTICS | WHITFIELD ROY A | Director | Sep 16, 2021 | Option Exercise | $13.80 | 40,000 | 552,000 | 225,850 | Sep 17, 2021, 06:44 PM |
NKTR | | NEKTAR THERAPEUTICS | CHESS ROBERT | Director | Sep 08, 2021 | Sale | $14.90 | 16,000 | 238,400 | 282,273 | Sep 10, 2021, 06:03 PM |
NKTR | | NEKTAR THERAPEUTICS | CHESS ROBERT | Director | Sep 09, 2021 | Sale | $14.91 | 20,558 | 306,520 | 284,552 | Sep 10, 2021, 06:03 PM |
NKTR | | NEKTAR THERAPEUTICS | GREER R SCOTT | Director | Aug 31, 2021 | Option Exercise | $12.70 | 45,000 | 571,500 | 270,674 | Aug 31, 2021, 06:26 PM |
NKTR | | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | Aug 16, 2021 | Sale | $13.83 | 7,662 | 105,965 | 212,803 | Aug 18, 2021, 07:04 PM |
NKTR | | NEKTAR THERAPEUTICS | Wilson Mark Andrew | SVP & General Counsel | Aug 16, 2021 | Sale | $13.83 | 1,910 | 26,415 | 72,900 | Aug 18, 2021, 07:02 PM |
NKTR | | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | Aug 16, 2021 | Sale | $13.83 | 11,515 | 159,252 | 424,123 | Aug 18, 2021, 07:01 PM |
NKTR | | NEKTAR THERAPEUTICS | Thomsen Jillian B. | SVP & Chief Accounting Officer | Aug 16, 2021 | Sale | $13.83 | 13,339 | 184,478 | 137,822 | Aug 18, 2021, 07:00 PM |
NKTR | | NEKTAR THERAPEUTICS | NORTHCOTT JOHN | SVP & Chief Commercial Officer | Aug 16, 2021 | Sale | $13.83 | 6,192 | 85,635 | 200,915 | Aug 18, 2021, 06:59 PM |
NKTR | | NEKTAR THERAPEUTICS | Labrucherie Gil M | SVP, COO & CFO | Aug 16, 2021 | Sale | $13.83 | 7,867 | 108,801 | 243,231 | Aug 18, 2021, 06:58 PM |
NKTR | | NEKTAR THERAPEUTICS | Labrucherie Gil M | SVP, COO & CFO | Aug 17, 2021 | Sale | $13.56 | 3,000 | 40,680 | 240,231 | Aug 18, 2021, 06:58 PM |
NKTR | | NEKTAR THERAPEUTICS | CHESS ROBERT | Director | Jul 20, 2021 | Option Exercise | $15.30 | 4,212 | 64,444 | 282,679 | Jul 22, 2021, 07:13 PM |
NKTR | | NEKTAR THERAPEUTICS | CHESS ROBERT | Director | Jul 21, 2021 | Option Exercise | $15.30 | 7,048 | 107,870 | 284,097 | Jul 22, 2021, 07:13 PM |
NKTR | | NEKTAR THERAPEUTICS | CHESS ROBERT | Director | Jul 22, 2021 | Option Exercise | $15.30 | 182 | 2,785 | 280,664 | Jul 22, 2021, 07:13 PM |
NKTR | | NEKTAR THERAPEUTICS | Labrucherie Gil M | SVP, COO & CFO | May 17, 2021 | Sale | $18.30 | 7,898 | 144,533 | 251,098 | May 19, 2021, 07:04 PM |
NKTR | | NEKTAR THERAPEUTICS | CHESS ROBERT | Director | May 12, 2021 | Sale | $16.57 | 16,000 | 265,120 | 288,573 | May 14, 2021, 06:05 PM |
NKTR | | NEKTAR THERAPEUTICS | CHESS ROBERT | Director | Apr 14, 2021 | Sale | $16.39 | 16,000 | 262,240 | 288,573 | Apr 16, 2021, 06:02 PM |
NKTR | | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | Feb 16, 2021 | Sale | $22.37 | 24,141 | 540,034 | 266,176 | Feb 18, 2021, 07:07 PM |
NKTR | | NEKTAR THERAPEUTICS | Wilson Mark Andrew | SVP & General Counsel | Feb 16, 2021 | Sale | $22.37 | 2,173 | 48,610 | 76,727 | Feb 18, 2021, 07:06 PM |
NKTR | | NEKTAR THERAPEUTICS | Thomsen Jillian B. | SVP & Chief Accounting Officer | Feb 16, 2021 | Sale | $22.37 | 11,705 | 261,841 | 164,552 | Feb 18, 2021, 07:05 PM |
NKTR | | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | Feb 16, 2021 | Sale | $22.37 | 11,495 | 257,143 | 447,198 | Feb 18, 2021, 07:04 PM |
NKTR | | NEKTAR THERAPEUTICS | NORTHCOTT JOHN | SVP & Chief Commercial Officer | Feb 16, 2021 | Sale | $22.37 | 15,358 | 343,558 | 213,192 | Feb 18, 2021, 07:03 PM |
NKTR | | NEKTAR THERAPEUTICS | Labrucherie Gil M | SVP, COO & CFO | Feb 16, 2021 | Sale | $22.37 | 7,977 | 178,445 | 258,996 | Feb 18, 2021, 07:03 PM |
NKTR | | NEKTAR THERAPEUTICS | Wilson Mark Andrew | SVP & General Counsel | Feb 03, 2021 | Option Exercise | $14.13 | 10,688 | 150,968 | 84,244 | Feb 04, 2021, 08:44 PM |
NKTR | | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | Feb 02, 2021 | Sale | $14.29 | 300,000 | 4,286,025 | 608,693 | Feb 04, 2021, 08:43 PM |
NKTR | | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | Feb 03, 2021 | Sale | $14.26 | 300,000 | 4,278,000 | 608,693 | Feb 04, 2021, 08:43 PM |
NKTR | | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | Feb 04, 2021 | Sale | $14.54 | 300,000 | 4,362,906 | 608,693 | Feb 04, 2021, 08:43 PM |
NKTR | | NEKTAR THERAPEUTICS | Labrucherie Gil M | SVP, COO & CFO | Feb 04, 2021 | Option Exercise | $14.30 | 100,000 | 1,430,500 | 316,973 | Feb 04, 2021, 08:42 PM |
NKTR | | NEKTAR THERAPEUTICS | Labrucherie Gil M | SVP, COO & CFO | Feb 02, 2021 | Option Exercise | $14.49 | 100,000 | 1,448,629 | 316,973 | Feb 04, 2021, 08:42 PM |
NKTR | | NEKTAR THERAPEUTICS | Labrucherie Gil M | SVP, COO & CFO | Feb 03, 2021 | Sale | $14.21 | 100,000 | 1,420,500 | 316,973 | Feb 04, 2021, 08:42 PM |
NKTR | | NEKTAR THERAPEUTICS | Thomsen Jillian B. | SVP & Chief Accounting Officer | Jan 28, 2021 | Option Exercise | $13.71 | 150,000 | 2,056,500 | 251,257 | Jan 29, 2021, 06:10 PM |
NKTR | | NEKTAR THERAPEUTICS | GREER R SCOTT | Director | Jan 05, 2021 | Option Exercise | $13.80 | 40,000 | 552,000 | 225,674 | Jan 05, 2021, 05:09 PM |
NKTR | | NEKTAR THERAPEUTICS | Myriam Curet | Director | Dec 15, 2020 | Sale | $17.82 | 1,560 | 27,799 | 19,240 | Dec 17, 2020, 06:08 PM |
NKTR | | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | Nov 23, 2020 | Sale | $16.40 | 16,380 | 268,632 | 250,317 | Nov 25, 2020, 06:09 PM |
NKTR | | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Chief R&D Officer | Nov 16, 2020 | Sale | $16.93 | 29,618 | 501,433 | 266,697 | Nov 18, 2020, 07:08 PM |
NKTR | | NEKTAR THERAPEUTICS | Wilson Mark Andrew | SVP & General Counsel | Nov 16, 2020 | Sale | $16.93 | 1,539 | 26,055 | 49,850 | Nov 18, 2020, 07:07 PM |
NKTR | | NEKTAR THERAPEUTICS | Thomsen Jillian B. | SVP & Chief Accounting Officer | Nov 16, 2020 | Sale | $16.93 | 11,976 | 202,754 | 159,757 | Nov 18, 2020, 07:05 PM |
NKTR | | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | Nov 16, 2020 | Sale | $16.93 | 11,975 | 202,737 | 352,043 | Nov 18, 2020, 07:04 PM |
NKTR | | NEKTAR THERAPEUTICS | Labrucherie Gil M | SVP, COO & CFO | Nov 16, 2020 | Sale | $16.93 | 8,276 | 140,113 | 226,973 | Nov 18, 2020, 07:03 PM |
NKTR | | NEKTAR THERAPEUTICS | Ajer Jeffrey Robert | Director | Sep 28, 2020 | Sale | $17.25 | 3,250 | 56,063 | 25,975 | Sep 30, 2020, 07:03 PM |
NKTR | | NEKTAR THERAPEUTICS | CHESS ROBERT | Director | Sep 25, 2020 | Sale | $17.75 | 5,500 | 97,625 | 280,573 | Sep 25, 2020, 08:16 PM |
NKTR | | NEKTAR THERAPEUTICS | Labrucherie Gil M | SVP, COO & CFO | Sep 17, 2020 | Sale | $19.96 | 2,000 | 39,920 | 235,249 | Sep 21, 2020, 08:59 PM |
NKTR | | NEKTAR THERAPEUTICS | Ajer Jeffrey Robert | Director | Sep 21, 2020 | Sale | $19.74 | 2,250 | 44,415 | 20,125 | Sep 21, 2020, 08:58 PM |
NKTR | | NEKTAR THERAPEUTICS | CHESS ROBERT | Director | Sep 08, 2020 | Option Exercise | $13.89 | 16,000 | 222,160 | 284,973 | Sep 10, 2020, 08:19 PM |